Richard W. Paul & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38K | Hold |
20
| – | – | ﹤0.01% | 314 |
|
|
2025
Q1 | $1.39K | Sell |
20
-120
| -86% | -$8.33K | ﹤0.01% | 308 |
|
|
2024
Q4 | $12K | Buy |
140
+20
| +17% | +$1.72K | ﹤0.01% | 295 |
|
|
2024
Q3 | $14.3K | Hold |
120
| – | – | 0.01% | 286 |
|
|
2024
Q2 | $17.1K | Hold |
120
| – | – | 0.01% | 265 |
|
|
2024
Q1 | $15.4K | Hold |
120
| – | – | 0.01% | 290 |
|
|
2023
Q4 | $12.4K | Hold |
120
| – | – | 0.01% | 292 |
|
|
2023
Q3 | $10.9K | Hold |
120
| – | – | 0.01% | 286 |
|
|
2023
Q2 | $9.71K | Hold |
120
| – | – | ﹤0.01% | 317 |
|
|
2023
Q1 | $9.55K | Hold |
120
| – | – | ﹤0.01% | 324 |
|
|
2022
Q4 | $8.12K | Buy |
+120
| New | +$8.12K | ﹤0.01% | 337 |
|